RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways https://www.biorxiv.org/content/10.1101/2023.06.09.544432v1?med=mas
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.